EyePoint Pharmaceuticals Competitors and Similar CompaniesClear all
EyePoint Pharmaceuticals's competitors and similar companies include Sol-Gel Technologies, Alentis Therapeutics, dMed and Aquestive Therapeutics.
 EyePoint Pharmaceuticals EyePoint Pharmaceuticals (formerly pSivida) is a pharmaceutical company focused on the development of innovative miniaturized, sustained-release drug delivery products and technologies to treat serious, debilitating diseases of the eye that can lead to blindness. |  Sol-Gel Technologies Sol-Gel Technologies is engaged in the development of a range of specialty pharmaceuticals. |  Alentis Therapeutics Alentis Therapeutics is a company that discovers and develops medications to treat liver diseases. |  dMed dMed is a biopharmaceutical company that facilitates the globalization of innovative drugs, accelerates the development of medicines and improves clinical development capabilities. |  Aquestive Therapeutics Aquestive Therapeutics is a pharmaceutical company that is engaged in drug development using PharmFilm technology. | |
Founding Date | Founding Date 1987 | Founding Date 1997 | Founding Date 1993 | Founding Date 2016 | Founding Date 2004 |
Type | Type Public | Type Public | Type Private | Type Private | Type Public |
Tags | |||||
Locations | Locations Watertown, US HQ | Locations Ness Ziona, IL HQ | Locations Basel, CH HQ | Locations Morrisville, US HQ | Locations Warren, US HQ |
Employees | Employees 8453% increase | Employees 34 | Employees N/A | Employees 172 | Employees 13017% decrease |
Valuation ($) | Valuation ($) 617.6 m | Valuation ($) 18 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 515.4 m |
Financial | |||||
Revenue (est.) | Revenue (est.) $31.4m (FY, 2025) | Revenue (est.) $19.4m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $44.5m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods $18.6m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit $19.4m (FY, 2025) | Gross profit N/A | Gross profit N/A | Gross profit $26m (FY, 2025) |
Net income | Net income ($232m) (FY, 2025) | Net income ($6.1m) (FY, 2025) | Net income N/A | Net income N/A | Net income ($83.8m) (FY, 2025) |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 67m (almost 5 years ago) | Latest funding round $ 50m (almost 5 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 40m | Total funding raised N/A | Total funding raised $ 95.3m | Total funding raised $ 208m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Sol-Gel Technologies
HQ
Ness Ziona, IL
Employees
34
Sol-Gel Technologies is engaged in the development of a range of specialty pharmaceuticals.
View companyAlentis Therapeutics
HQ
Basel, CH
Alentis Therapeutics is a company that discovers and develops medications to treat liver diseases.
View companydMed
HQ
Morrisville, US
Employees
172
dMed is a biopharmaceutical company that facilitates the globalization of innovative drugs, accelerates the development of medicines and improves clinical development capabilities.
View companyAquestive Therapeutics
HQ
Warren, US
Employees
130↓ 17% decrease
Aquestive Therapeutics is a pharmaceutical company that is engaged in drug development using PharmFilm technology.
View company